// App-Quantinova.ai

3392 : Early Recovery Of Absolute Lymphocyte Counts ? 0.2x109/L At Day 21 Can Predict Reduced Risk Of Relapse In Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation

Researchers

Presenter

  • Feras Alfraih

Principal Investigators

  • Dennis Dong Hwan Kim

  • John Kuruvilla

  • Hans A. Messner

  • Jeffrey H. Lipton

  • Vikas Gupta

Medical Centers

  • Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

  • Lymphocyte count

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved